AT

Atomera Inc.

Licenses patented material IP (MST®) to create higher-performance, lower-power semiconductors.

ATOM | NDAQ

Overview

Corporate Details

ISIN(s):
US04965B1008
LEI:
Country:
United States of America
Address:
N/A
Website:
atomera.com
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Atomera Inc. is a semiconductor materials and intellectual property (IP) licensing company that develops, commercializes, and licenses proprietary technologies for the semiconductor industry. The company's core offering is its patented Mears Silicon Technology (MST®), a quantum-engineered material designed to enhance transistors. MST improves semiconductor performance by enabling faster and more controlled electron movement and better diffusion control of dopants. This technology allows manufacturers to create chips with higher performance, lower power consumption, and increased density. Atomera targets markets including mobile/5G, Internet of Things (IoT), and infrastructure, with applications spanning logic and processors, memory (DRAM, SRAM), FinFETs, analog and power devices, and image sensors. The company supports its licensees with engineering services and simulation tools like MSTcad™.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Atomera Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Atomera Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Korean CRO offering end-to-end clinical trial services for pharma & bio ventures.
South Korea 187660
HYUNDAI BIOSCIENCE CO., LTD. Logo
Clinical-stage biotech developing safer antiviral & anticancer drugs via advanced drug delivery systems.
South Korea 048410
IMGT Corporation Limited Logo
Develops a drug delivery platform using ultrasound and nanotech for oncology.
South Korea 456570
Immunic AG Logo
Developing oral therapies for autoimmune diseases like multiple sclerosis and celiac disease.
United States of America IMUX
Operates one of Japan's largest ad networks and a 'Furusato Nozei' tax donation website.
Japan 6535
INBIOGEN CO.,Ltd Logo
Data mining, bioinformatics, and virtual assistance for the life sciences industry.
South Korea 101140
Incross Co.,Ltd. Logo
A digital marketing firm offering data-driven ad solutions via proprietary AI and video platforms.
South Korea 216050
INEST,Inc. Logo
Offers ASP solutions and HR support to businesses and sells mobile devices to consumers.
Japan 7111
Innate Pharma Logo
Clinical-stage biotech developing NK cell-engaging antibodies for cancer immunotherapy.
France IPH
Innovation Inc. Logo
Drives B2B growth via digital media, IT solutions, M&A advisory, and venture capital.
Japan 3970

Talk to a Data Expert

Have a question? We'll get back to you promptly.